baber/WOPTO huggingface dataset:
Patent ES-2408336-B2 (ES)
Title: Dispositivo aerogenerador de movimiento alternativo de vaivén
Inventor: SAENZ-DIEZ MURO JUAN CARLOS
IPC: F03D9/14
Filed: 2013-01-10
Granted: 2013-12-10
Abstract: Dispositivo aerogenerador de movimiento alternativo de vaivén que dispone de palas con la finalidad de captar energía cinética del flujo de aire así como de las turbulencias del mismo, a partir del movimiento de vaivén que le producen, para almacenamiento de dicha energía en forma de energía potencial en un fluido, y posteriormente, y de forma preferentemente programada, convertirla en energía eléctrica. Está provisto de un mecanismo que permite que el movimiento de vaivén que produce cada pala, debido al impacto del viento, accione una bomba de émbolo alternativo, de las que se dispone una por cada pala, con las que se bombea agua de un depósito inferior a un depósito superior. Se complementa con un grupo turbina-generador para turbinar el agua del depósito superior hacia el depósito inferior para generación de energía eléctrica.
Patent IE-S86443-B2 (IE)
Title: A front panel for a fireplace insert appliance
Inventor: STACK MICHAEL
IPC: F24B13/00
Filed: 2013-02-01
Abstract: The present invention relates to a front panel (3) for a fireplace insert appliance (1) comprising an inner panel (4) and an outer panel(5) whereby inlet means (9) for channelling ambient air (A) into the appliance (1) is provided between the inner panel (4) and the outer panel (5). The inlet means (9) is provided as a gap or spacing between the inner panel (4) and the outer panel (5). The provision of an inlet means (9) provides a thermal break which reduces the conduction of heat from the inner panel (4) to the outer panel (5) which could potentially radiate onto drapes, furniture and other combustibles in proximity to the appliance, thereby reducing the chance of such combustibles being heated to flashpoint and causing a fire. The ambient air 'A’ flowing through the inlet means (9) is pre-heated as it flows through the cavities of the appliance (1), thereby lowering the temperature of the front panel (3) which reduces clearances to combustibles. <Figure 1>
Patent AU-2001257456-B2 (AU)
Title: A core formulation
Inventor: CUTIE ANTHONY J
IPC: A61K31/4439
Filed: 2001-05-01
Granted: 2006-02-09
Abstract: This invention relates to a combination drug product comprising rosiglitazone and a biguanide. In particular, the product comprises a core of metformin, at least a portion thereof has a layer or coat thereon of rosiglitazone.
Patent AU-2001262463-B2 (AU)
Title: Method for controlling channel handover in a cellular radiocommunication network
Inventor: FAUCONNIER DENIS
IPC: H04L9/16
Filed: 2001-05-18
Granted: 2005-09-22
Abstract: The infrastructure comprises a network core, and radio network controllers linked to the core of the network. Base stations are provided with radio interfaces and are each connected to one of the controllers. A second path is established in a transfer procedure comprising the transmission of control data from the first to a second master controller, and the suppression of the first path. The infrastructure comprises a network core, and radio network controllers linked to the core of the network. Base stations are provided with radio interfaces and are each connected to one of the controllers. Digital information is transmitted on a first communication path in circuit mode between the core of the network and the terminal, passing through a first master controller, then on a second communication path in circuit mode between the core of the network and the terminal, passing through a second master controller. The second path is established in a transfer procedure comprising the transmission of control data from the first to the second master controller, and the suppression of the first path. This control data is representative of a current value of a sequence number used to number the information, incremented at regular intervals, and a shift between this sequence number and a time reference available to the second controller.
Patent AU-2002236757-B2 (AU)
Title: Assemble-in-place modular storage
Inventor: SARAVIS DARREN
IPC: F16B12/26
Filed: 2002-01-11
Granted: 2006-04-27
Abstract: A modular storage rack, display structural element or cube system formed by snap together panels with alignment guides, which may also support wheels, shelves, drawers and doors. The system is assemble-in-place and may shipped and displayed for sale in a flat pack.
Patent AU-2002242875-B2 (AU)
Title: Condom with an erectogenic composition
Inventor: KEMP COLIN ANTHONY
IPC: A61K31/485
Filed: 2002-03-28
Granted: 2005-12-22
Abstract: A condom has an erectogenic compound immobilised on the interior surface and substantially at the head end thereof. The compound may be applied as a component of a composition comprising the erectogenic compound dispersed or dissolved in a gel carrier comprising a liquid medium including a thickening agent. The condom may include a lubricant which may be immiscible with the erectogenic compound or composition. Use of the condom sustains e penile erection following spontaneous initiation thereof, to prevent slippage of the condom off the penis while intercourse takes place.
Patent AU-2002364956-B2 (AU)
Title: Polycistronic expression of antibodies
Inventor: BARNETT RICHARD
IPC: C07K16/00
Filed: 2002-11-18
Granted: 2008-09-11
Abstract: Described herein is a eukaryotic cell that is stably transfected with a polycistronic vector for expressing functional antibodies, the vector comprises a polycistronic transcription system comprising the following elements operably linked in the 5' to 3' orientation: (i) a promoter operable in a eukaryotic cell; (ii) a first cistron comprising a first DNA sequence comprising a 5' start codon, a nucleotide sequence encoding an antibody light chain, and a 3' terminal stop codon, wherein said first DNA sequence does not comprise a poly A sequence at its 3' end; (iii) an internal ribosome entry site (IRES) obtained from a member selected from the group consisting of a cardiovirus, a herpes virus and a poliovirus; (iv) at least an additional cistron comprising a second DNA sequence comprising a 5' start codon, a nucleotide sequence encoding an antibody heavy chain, and a 3' terminal stop codon, wherein said second DNA sequence comprises a poly A sequence at its 3' terminus; wherein the IRES is operably linked to the 5' end of the additional cistron with no intervening regulatory elements; and wherein the functional antibodies expressed by the polycistronic vector specifically bind to a tumor associated antigen. Further described is a method of producing functional antibodies comprising culturing the eukaryotic cell of the invention in a cell culture to produce functional antibodies.
Patent AU-2002365130-B2 (AU)
Title: Antimicrobial radiation curable coating
Inventor: WATTERSON ROBERT S
IPC: C08K5/10
Filed: 2002-10-09
Granted: 2006-10-19
Abstract: The invention is a radiation curable coating containing an antimicrobial agent, where upon irradiation with UV light, the radiation curable coating rapidly cures to a polymeric coating. The polymeric coating has durable antimicrobial properties, being especially effective at preventing the growth of Staphylococcus aureaus and Kleibsella pneumoniae on wood flooring and furniture. The major components in the radiation curable coating are a urethane acrylic oligomer, a radiation cure package, an antimicrobial agent, a cross-linking agent, and optionally, an additive package. The radiation curable urethane oligomer is a relatively short chain backbone urethane polymer that is end capped with a radiation curable moiety, where the moiety is an acrylic. The cross-linking agent is one or more monomers used to lower the viscosity and promote cross-linking, and include acrylate esters of mono-, di-, tri-, or tetrafunctional alcohols. The radiation cure package contains at least one photoinitiator.
Patent AU-2003224001-B2 (AU)
Title: Tumour-associated peptides that bond to MHC molecules
Inventor: RAMMENSEE HANS GEORG
IPC: A61K39/00
Filed: 2003-03-27
Granted: 2010-03-11
Abstract: Tumor-associated peptides (I) having any of 79 sequences, reproduced, are new. (I) can bind to a Class I molecule of the human major histocompatibility complex (MHC). Independent claims are also included for the following: (1) nucleic acid (II) that encodes (I); (2) vector that contains (II); and (3) cell modified to express (I), by incorporation of (II) or the vector of (2). ACTIVITY : Cytostatic. MECHANISM OF ACTION : Vaccine; induction of cytotoxic T lymphocytes (CTL). Dendritic cells (0.5 million) were isolated from peripheral blood and incubated with peptide (1) at 50 mu g/ml for 2 hours, then washed and incubated with 2.5 million autologous peripheral blood mononuclear cells (PBMC) for 7 days. The cells were restimulated with interleukin-2 (1 ng/ml) on days 1, 3 and 5, then cytotoxicity tested against various cancer cells at effector:target ratio 30:1, in a standard 51chromium release assay. Typical specific lysis scores were over 30% for HCT 116 stomach cancer cells; over 60% for A498 renal cancer cells; about 40% for MEL1479 melanoma and about 50% for MCF-7 breast cancer cells. Tyr-Val-Asp-Pro-Val-Ile-Thr-Ser-Ile (1).
Patent AU-2003264221-B2 (AU)
Title: Set and method for producing a hearing aid and hearing aid produced according to this method
Inventor: LANCI ANTONINO
IPC: H04R25/00
Filed: 2003-09-26
Granted: 2009-04-23
Abstract: A hearing aid includes a shaped body that is adapted to an individual auditory canal. A casting cavity is created from a central casting space element, an outer casting space element, and a canal element. The casting cavity is filled while inside the auditory canal. The central casting space element, which remains on the hearing aid, has an outer and an inner ring as well as a tubular and extendible membrane. The outer casting space element delimits the casting cavity on the outer face. After casting, the outer casting space element is replaced by an electronics module including a loudspeaker. The at least partly flexible canal element can hold the loudspeaker canal open, can be joined in a fixed or detachable manner to the outer casting space element, and can essentially close the opening of the inner ring and can limit the axial mobility of the inner ring.
Patent AU-2003277072-B2 (AU)
Title: Two-way locking device for height safety apparatus.
Inventor: FLUX PETER ROBERT
IPC: A62B35/04
Filed: 2003-06-13
Granted: 2009-10-22
Abstract: A fall arrest device having a safety support whilst allowing movement of the device on an elongate support. The fall arrest device including, a sliding element, first and second cam elements, first and second links, and an attachment. The first and second links connected together to mutually rotate about a third axis separated from a first and second axes, and the attachment moving relative to the links, so that the first and second locking cams can be moved between their first and second positions by loads applied to the device through the attachment.
Patent AU-2003282616-B2 (AU)
Title: Method and apparatus for replacing a mitral valve with a stentless bioprosthetic valve
Inventor: NAVIA JOSE A
IPC: A61F/
Filed: 2003-10-10
Granted: 2006-06-29
Abstract: A stentless bioprosthetic valve includes at least one piece of biocompatible material comprising a bi-leaflet conduit having a proximal end and a distal end. The proximal end defines a first annulus for suturing to the valve annulus. The conduit includes first and second leaflets that mimic the native leaflets and extend between the conduit ends. The distal end defines a second annulus at which the first and second leaflets terminate. The conduit further includes first and second pairs of prosthetic chordae projecting from the leaflets at the second annulus. One of the first pair of prosthetic chordae extends from the first leaflet and has a distal end for suturing to a papillary muscle and the other of the first pair of prosthetic chordae extends from the first leaflet and has a distal end for suturing to another papillary muscles.
Patent AU-2004228764-B2 (AU)
Title: Intramedullary nail for femur fracture fixation
Inventor: ASCHMANN FELIX
IPC: A61B17/74
Filed: 2004-04-07
Granted: 2007-10-04
Abstract: An intramedullary nail for the fixation of fractures of the proximal femur, with a femur neck screw (10a), installable with a proximal femur nail (1a), into the intramedullary area, by a diagonal bore (7a), running to the longitudinal axis of the femur nail (1a), from the side of the femur nail (1a), and a locking element (16a) with at least one prong (18a) parallel to the axis of the femur neck screw (10a). A positive connection between the locking element (16a) and a groove (8a) in the bore (7a) of the femur nail (1a) forms a twisting lock of the femur neck screw (10a) and, allows for the axial movement of the femur neck screw (10a) in the bore (7a) of the femur nail (1a).
Patent AU-2004281071-B2 (AU)
Title: Sandwich press and grill
Inventor: SERRA DANIEL
IPC: A47J37/06
Filed: 2004-10-13
Granted: 2008-07-17
Abstract: There is provided a toaster grill (100) having a lower housing (102) that supports a lower cooking surface (104) and an upper housing (109) that supports an upper cooking surface (110). The upper housing pivots with respect to a "U" shaped frame (204) that is hinged with respect to the lower cooking surface. A hinge locking mechanism defines a locked intermediate orientation between the lower (102) and upper (109) housing.
Patent AU-2004299286-B2 (AU)
Title: 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them
Inventor: FRANCOIS PUCCIO
IPC: C07D409/12
Filed: 2004-12-15
Granted: 2011-06-30
Abstract: The invention relates to the compounds of formula (I), in which R, R, R, R, Q and Z are as defined in the specification. The invention also relates to the pharmaceutical compositions containing these compounds. The invention generally relates to the field of hormone- and non hormone-dependent cancer and endocrine disorders.
Patent AU-2005262050-B2 (AU)
Title: Use of L-carnitine and glucose for the treatment of cardiovascular diseases
Inventor: KOVERECH ALEARDO
IPC: A61P9/10
Filed: 2005-06-21
Granted: 2011-02-24
Abstract: The use of L-carnitine, or one of its pharmaceutically acceptable salts, is described in combination with glucose for the preparation of a medicament useful for diminishing the number of deaths caused by acute myocardial infarction, for reducing the number of days infarction patients spend in intensive care in hospital, and for reducing the number of episodes of post-infarction heart failure, in which the L-carnitine is administered intravenously within only a few hours of the onset of symptoms of acute myocardial infarction at an initial dose of 9 grams a day in combination with 1000-1500 mL of a 5% glucose solution for 5 days, after which the L-carnitine treatment is continued at a dose of 4 grams a day administered orally.
Patent AU-2005326876-B2 (AU)
Title: Air conditioner
Inventor: YOO JOONG GIL
IPC: F24F1/0057
Filed: 2005-12-26
Granted: 2009-04-23
Abstract: An air conditioner is provided. In the air conditioner, a panel frame (190) is mounted on a front of a main body (110), a front panel (120) is movably installed in the panel frame (190), and a front cover (130) is detachably mounted on the front panel (120).
Patent AU-2005334837-B2 (AU)
Title: PH-controlled pulsatile delivery system, methods for preparation and use thereof
Inventor: SCHELLEKENS REINOUT CORNELUS ANDREAS
IPC: A61K39/00
Filed: 2005-07-29
Granted: 2012-07-19
Abstract: The invention relates to delivery systems that allow for the pulsatile release of a substance, such as a drug, in response to a change in pH. More specifically, it relates to drug administration to the GI tract, in particular to site-specific intestinal drug delivery via the oral route. Provided is a pH-controlled pulsatile release system (PPRS) comprising a core surrounded by a coating layer, wherein said core comprises an active substance and wherein said coating layer comprises a pH-sensitive coating material wherein a swellable agent is embedded. Said swellable agent is capable of taking up at least 1.1 times, preferably at least 5 times, more preferably at least 10 times its weight in water. Also provided is a pharmaceutical composition comprising a PPRS, in particular a colon-specific PPRS.
Patent AU-2005338967-B2 (AU)
Title: Nonwoven material and absorbing article comprising nonwoven material
Inventor: BURMAN DANIEL
IPC: A61F13/15
Filed: 2005-12-07
Granted: 2012-05-17
Abstract: The present invention relates to a nonwoven material intended for use in absorbent products produced by the hydroentangling of a substrate web comprising at least one layer of fibres selected from amongst synthetic fibres, regenerated fibres and natural fibres, wherein the nonwoven material (1) has a base level ho with protuberances (2, 3) on one side, wherein the protuberances (2, 3) form at least a first and a second surface structure respectively in the form of first (2) and second (3) protuberances from the base level h0, wherein the first protuberances (2) have a height hi from the base level and the second protuberances (3) have a height h2 from the base level h0, where h2 is higher than hj, and each of the second protuberances (3) occupies an area of the surface of Hie base level at least 4 times greater than each of the first protuberances (2). The invention also relates to an absorbent product containing a nonwoven material in accordance with the above.
Patent AU-2006222408-B2 (AU)
Title: A folding plastic clip for pleated blinds
Inventor: ANDERSEN TORBEN MEYER
IPC: E06B9/42
Filed: 2006-03-07
Granted: 2012-03-15
Abstract: Traditional fixing of raising cords on pleated blinds occurs by means of plastic flaps sewn in place that hold knots on the raising cords. Adjustment of tension in the raising cords is difficult, because it may be required to loosen the knot and re-tie it i a better location. According to the invention this is avoided in that a plastic clip has slits, in which the raising cords are pinched and locked after being wound 1½ turn around an interjacent tongue in the plane of the plastic clip.
Patent AU-2006251093-B2 (AU)
Title: Steel for submarine hulls with improved weldability
Inventor: JEAN BEGUINOT
IPC: C22C38/08
Filed: 2006-05-19
Granted: 2011-09-22
Abstract: The invention relates to a steel for the production of submarine hulls, which is characterised in that the chemical composition thereof comprises, by weight percent: 0.03 % ≤ C < 0.08 %; 0.04 % ≤ Si ≤ 0.48 %; 0.1 % ≤ Mn ≤ 1.4 %; 2 % ≤ Ni ≤ 4 %; Cr ≤ 0.3 %; 0.3 % ≤ Mo + W/2 + 3 (V + Nb/2 + Ta/4) ≤ 0.89 %; Mo ≥ 0.15 %; V + Nb/2 + Ta/4 ≤ 0.004 %; Nb ≤ 0.004 %; Cu ≤ 0.45 %; Al ≤ 0.1 %; Ti ≤ 0.04 %; N ≤ 0.03 %; the remainder comprising iron and impurities resulting from production, boron being an impurity with a concentration of less than 0.0005 %, and P + S ≤ 0.015 %, the chemical composition satisfying condition 410 ≤ 540 x C+ 245 [ Mo + W/2 + 3 (V + Nb/2 + Ta/4)] ≤ 460. The inventive steel has an essentially martensitic or lower bainitic structure comprising at least 90 % martensite or lower bainite, at most 5 % residual austenite, at most 5 % ferrite. The steel has a yield strength of between 480 MPa and 620 Mpa and a Charpy toughness V, K at -60 °C of more than 50J.
Patent AU-2006343774-B2 (AU)
Title: Medical-use bandage.
Inventor: TAMBOURGI CHRISTINA
IPC: A61M25/02
Filed: 2006-08-30
Granted: 2012-02-16
Abstract: The invention relates to a medical-use bandage (1) designed to immobilize a tube implanted in a body, the implanted tube defining an exit site from the body and a part of the tube projecting from the body; the bandage comprising: - a base support (2) having a lower face (21) designed to be applied to the skin and an upper face (22) , - first fixing means (3) for fixing the exit site, comprising on the lower face (21) of the base support (2) an adhesive fixing part (32) designed to be stuck at least partly around the exit site to the skin and to a proximal portion of the projecting part of the tube; and - second fixing means (4) for engaging the distal portion of the projecting part of the tube in a defined shape and in a sliding manner, the second fixing means (4) consisting at least partly of a part (43) of the upper face (22) of the support (2) .
Patent AU-2007241829-B2 (AU)
Title: Fluid container and airless fluid dispensing system
Inventor: KAMISHITA TAIZOU
IPC: A61K47/18
Filed: 2007-04-20
Granted: 2012-11-29
Abstract: A fluid container of the invention has a container body provided with a shoulder and a sidewall that extend between an upper opening and a lower opening. The fluid container has a spacer provided adjacent to the shoulder of the container body. Further, a slide valve and a bottom cover are placed in the container body. The slide valve is liquid-tightly slidable along the inner surface of the sidewall of the container body and forms a fluid holding container space between itself and the sidewall of the container body. The bottom cover covers the lower opening of the container body. The spacer and the slide valve have a spacer surface and a valve surface, respectively, which face to each other, and the spacer surface and the valve surface are tilted at an angle in the range from 5 degrees to 30 degrees relative to a horizontal plane. Accordingly, an airless fluid dispensing system using the fluid container reliably prevents a small amount of air from remaining in the container body during fluid filling and can dispense a predetermined amount of fluid without unnecessary pumping operation before use.
Patent AU-2007244955-B2 (AU)
Title: Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
Inventor: MARTIN HANSEN MARVIN
IPC: C07D207/26
Filed: 2007-04-23
Granted: 2011-12-08
Abstract: The present invention discloses novel compounds of Formula I: (I) having 11 -HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11 -HSD type 1 activity.
Patent AU-2007323368-B2 (AU)
Title: 2 -Alkyl- indazole compounds for the treatment of certain CNS-related disorders
Inventor: OMBRATO ROSELLA
IPC: A61K31/435
Filed: 2007-11-19
Granted: 2013-02-07
Abstract: 2-Alkyl-indazole compound and its pharmaceutically acceptable salts of acid addition, method and intermediates for preparing them, a pharmaceutical composition containing them and use of the latter. The 2-alkyl-indazole compound has the following general formula (I) in which R1, R2, R3, R4, R6, R7, X, Y, W, n, p, and m have the meanings stated in the description.
Patent AU-2007333729-B2 (AU)
Title: Dairy compositions and method of making
Inventor: SEGUIN RICHARD J
IPC: A23G3/34
Filed: 2007-12-18
Granted: 2013-05-09
Abstract: The invention relates to a method of separating components from milk. The invention also relates to compositions prepared from the separated components. The present invention relates to nutritional milk compositions and products which are designed to include per serving size a specified percentage range of one or more components separated from milk. The compositions of the present invention can optionally include non-essential but nutritionally functional components. The complete nutritional milk compositions of the present invention can be provided as unflavored milks, flavored milks, ice creams, yogurts and milk powders.